Equities

Tianjin TEDA Biomedical Engineering Co Ltd

Tianjin TEDA Biomedical Engineering Co Ltd

Actions
  • Price (HKD)0.22
  • Today's Change0.00 / 0.00%
  • Shares traded270.00k
  • 1 Year change+144.44%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments5.939.5530
Total Receivables, Net184543
Total Inventory907475
Prepaid expenses616456
Other current assets, total1504.95
Total current assets190193209
Property, plant & equipment, net113132139
Goodwill, net05.530
Intangibles, net06.550.04
Long term investments----0
Note receivable - long term------
Other long term assets------
Total assets303337348
LIABILITIES
Accounts payable162130
Accrued expenses2.470.601.51
Notes payable/short-term debt62197.00
Current portion long-term debt/capital leases1.564838
Other current liabilities, total135130116
Total current liabilities217218192
Total long term debt203545
Total debt8410390
Deferred income tax1.562.56--
Minority interest15119.58
Other liabilities, total------
Total liabilities253267247
SHAREHOLDERS EQUITY
Common stock189189189
Additional paid-in capital275275275
Retained earnings (accumulated deficit)(415)(395)(364)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity5070101
Total liabilities & shareholders' equity303337348
Total common shares outstanding1,8951,8951,895
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.